Find a solution
Find a label
Search Bayer Reps
Please call our Bayer Technical Support Line on 1800 804 479 or use our contact form.

Bayer focuses on at the 2016 Brazilian Weed Congress


  • Date

    09 Juni, 2017



09 June, 2017

The life science company will launch the “Diversity is the Future” theme during the 30th Brazilian Weed Science Congress, in Curitiba (PR)
Diversity is the Future. Bayer kicked off its integrated weed management initiative in Brazil with this motto during the 30th Brazilian Weed Science Congress, scheduled for Curitiba (PR), from August 22-26.

In addition to the initiative, the new pre-emergence herbicide Alion®–for coffee, citrus, and sugarcane–as well as the post-emergence herbicide Liberty®, which was recently extended for the soybean crop, and the LibertyLink® technology, inserted into the soy varieties Bayer markets, marked the pillars the company highlighted during the event.

On the sidelines of the congress, the company had space set aside for the Diversity is the Future initiative, which featured a lecture by Christine Brunel-Ligneau, global leader of this front, and showcased Bayer’s efforts in Digital Farming and Stewardship areas, as well as of the Expertise Center for Tropical Agriculture (CEAT), which is in charge of technological solutions aimed at tropical production systems.

“Integrated weed management is a method of fighting and preventing weeds by using treated seeds, crop protection products developed with an advanced technological profile, and customized services for the prevention of tilling, in addition to promoting the best management practices in the farmer’s daily activities. When it comes to managing weeds, preventing is better than treating”, said Mario Lussari, Bayer’s Herbicide and Growth Regulator portfolio manager.

Bayer’s team with resistance management experts was present at several lectures throughout the week:

Harry John Strek, the global leader of the Bayer Weed Resistance Competence Center, was one of the speakers at the opening ceremony, on the 23rd, and addressed The challenge of discovering new herbicides and bringing them to the farmers.

Marcel Sereguim Cabral de Melo, a Bayer weed resistance monitoring specialist, spoke on the New Resistance Issues in Brazil - Grasses panel (8/23), with a talk about Sourgrass resistance to the haloxyfop-methyl and fenoxaprop-p-ethyl herbicides in Midwestern biotypes.
Adriana Ricci, Bayer’s Stewardship Manager, addressed Opportunities for women in the weed science area during the Participants’ Luncheon (room 4, 8/23).

Rodolfo Carvalho Cesar San Juan, responsible for agronomic development at Bayer, spoke, on the New Herbicides panel (8/24), about Alion (indaziflam): Innovation for the sugarcane, citrus, and coffee crops.

Bayer: Science for a better life
Bayer is a global company focused on Life Sciences in the areas of human and animal health care and agriculture. Its products and services are developed to benefit people and improve their quality of life. Additionally, the company aims to create value through innovation. Bayer is committed to the principles of sustainable development and to its social and ethical responsibilities as a citizen corporation. In 2015, the group hired about 117,000 people and had sales of € 46.3 billion. Investments totaled € 2.6 billion, and expenses with Research and Development added up to € 4.3 billion. These figures include the high-tech polymer business, the initial public offer of which took place on October 6 2015 as an independent company named Covestro.
For more information about the Crop Science division, visit our website: and our channels on the social networks: Facebook; Twitter; YouTube.

Information for the press

S2Publicom – Assessoria de Imprensa
Carlos Nascimento Jr.
Phone: (11) 3027-0210 / 98459-5253
Phone: (11) 3531-4961 / 99995-8329
Phone: (11) 3531-4957 / 98335-0082


Forward-looking statements
This press release may contain forward-looking statements made based on current assumptions and forecasts made by Bayer Group's management or its business divisions. Several known and unknown risks, uncertainties, and other factors may cause material differences between the Company's actual future results, financial condition, development or performance and the forecasts made herein. Such factors include those discussed in Bayer's public reports posted on its website.



09 June, 2017